While some stock analysts like the recent spate of consolidation among health insurers –including Anthem’s (ANTM) current effort to buy Cigna (CI) — Standard & Poor’s does not. Cigna has rejected Anthem’s current $54 billion offer, but a deal could still take place at a higher price. Although there are strategic benefits to combining the two companies, [...]
No comments:
Post a Comment